AGP Executive Report
Last update: an hour agoVaccine Trial: A Danish university has approved a Guinea-Bissau study that plans to withhold the hepatitis B birth dose from half of 14,000 newborns for six weeks. Guinea-Bissau officials have also reportedly approved it, while the CDC is said to be setting aside $1.6 million. Health experts condemn the design as unethical and warn that delaying vaccination could leave babies vulnerable to lifelong infection; reports say the trial has not yet resumed. Regional Digital Identity: Guinea-Bissau is among seven ECOWAS countries to launch the bloc’s biometric identity card. ECOWAS aims for member states to accept it at air, land and sea borders by December 2026, easing regional travel and identity checks. Animal Health: ECOWAS officials met in Togo to strengthen regional surveillance and early response to animal diseases, including avian flu and foot-and-mouth disease.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.